Cargando…

Safety Evaluation of Pharmaceuticals and Medical Devices International Regulatory Guidelines /

Safety Evaluation of Pharmaceuticals and Medical Devices has been written to provide complete, ready and clear guidance as to what nonclinical safety assessment tests need to be performed to move a regulated therapeutic medical product into and through the development process and to marketing approv...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Gad, Shayne C. (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer US : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4419-7449-5
003 DE-He213
005 20220127103704.0
007 cr nn 008mamaa
008 101029s2011 xxu| s |||| 0|eng d
020 |a 9781441974495  |9 978-1-4419-7449-5 
024 7 |a 10.1007/978-1-4419-7449-5  |2 doi 
050 4 |a RM300-666 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
082 0 4 |a 615  |2 23 
100 1 |a Gad, Shayne C.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Safety Evaluation of Pharmaceuticals and Medical Devices  |h [electronic resource] :  |b International Regulatory Guidelines /  |c by Shayne C. Gad. 
250 |a 1st ed. 2011. 
264 1 |a New York, NY :  |b Springer US :  |b Imprint: Springer,  |c 2011. 
300 |a XI, 126 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Preface -- Introduction to Safety Assessment in Drug and Medical Device Development -- Drugs: The General Case -- Ind Enabling Toxicology Programs -- Nonclinical Safety Evaluation Studies Conducted To Support Continued Clinical Development -- Supporting Marketing Applications -- Special Therapeutic Category And Route Of Administration Cases -- Device Safety Evaluation -- Appendix A -- INDEX. 
520 |a Safety Evaluation of Pharmaceuticals and Medical Devices has been written to provide complete, ready and clear guidance as to what nonclinical safety assessment tests need to be performed to move a regulated therapeutic medical product into and through the development process and to marketing approval. This intent is purposely extended to cover the closely related product types of vaccines, biotechnology products, gene therapy, cell therapy, and combination products into a single, concise guide for the process in all the major world market countries. The approach of this volume is to first address the broadest scope "general case" for the regulatory nonclinical safety evaluation by ICH and ISO adhering countries, then to branch out to cover the differences in requirements associated with specific therapeutic areas (such as oncology), major routes of administration (with oral being the general case, other routes starting with parentheral, dermal and inhalation are addressed). Large molecules biotechnology products are then considered, followed by special courses of product marketing approval, and finally the remaining national differences. 
650 0 |a Pharmacology. 
650 0 |a Pharmaceutical chemistry. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmacology. 
650 2 4 |a Pharmaceutics. 
650 2 4 |a Pharmacy. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781441974488 
776 0 8 |i Printed edition:  |z 9781489981875 
776 0 8 |i Printed edition:  |z 9781441974501 
776 0 8 |i Printed edition:  |z 9781071604472 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4419-7449-5  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)